Monoclonal Antibody Therapy in Alzheimer’s Disease

Monoclonal Antibody Therapy in Alzheimer’s Disease

Alzheimer’s disease is a neurodegenerative condition marked by the progressive deterioration of cognitive abilities, memory impairment, and the accumulation of abnormal proteins, specifically beta-amyloid plaques and tau tangles, within the brain. Despite extensive research efforts, Alzheimer’s dise...

Full description

Bibliographic Details
Main Authors: Monica Neațu, Anca Covaliu, Iulia Ioniță, Ana Jugurt, Eugenia Irene Davidescu, Bogdan Ovidiu Popescu
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmaceutics
Subjects:
Alzheimer’s disease
ß-amyloid
tau protein
passive immunotherapy
monoclonal antibodies
Online Access:https://www.mdpi.com/1999-4923/16/1/60

Internet

https://www.mdpi.com/1999-4923/16/1/60

Similar Items